Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05358535 · ClinicalTrials.gov registry record · Phase 3
Propofol and Etomidate Admixtures Comparisons Trial (PEAC Trial)
A Phase 3 study of Anesthesia and Anesthesia Complication, sponsored by University of Texas Southwestern Medical Center.
- Recruiting
- Registry status
- Phase 3
- Development phase
- 200
- Enrollment target
- 1
- Study location
NCT05358535 is a Phase 3 study of Anesthesia and Anesthesia Complication that is actively recruiting participants, run by University of Texas Southwestern Medical Center. The registered enrollment target is 200 participants, below the 109,407-participant average among 57 other Anesthesia trials with a reported enrollment target (100% lower). The trial reports 1 study location across 1 state.
The verdict
NCT05358535, a Phase 3 study of Anesthesia and Anesthesia Complication, is actively recruiting participants, sponsored by University of Texas Southwestern Medical Center.
- RECRUITING
- Registry status
- Phase 3
- Development phase
- 200 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to evaluate the hemodynamics and adverse event profile in comparison between two treatment arms, one using an admixture of propofol and etomidate at a ratio by volume of 25%/75% (P2E7), and one using an admixture of propofol and etomidate at a ratio by volume of 75%/25% (P7E2), for anesthesia during endoscopic procedures at the Clements University Hospital (CUH) endoscopy lab (Endo).
Conditions Studied
Interventions
- DRUG Admixture of propofol and etomidate at a ratio by volume of 75%/25% (P7E2)
- DRUG Admixture of propofol and etomidate at a ratio by volume of 25%/75% (P2E7)
Study Locations (1)
Texas
- Clements University Hospital - Dallas
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 200 participants |
| Start Date | 2022-09-19 |
| Est. Completion | 2027-03 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05358535
The ClinicalTrials.gov registry entry for NCT05358535 describes a study currently listed as recruiting, categorized as Phase 3. The registered enrollment target is 200 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 109,407-participant average among 57 other Anesthesia trials with a reported enrollment target (100% lower). The listed sponsor is University of Texas Southwestern Medical Center, which has 837 total studies on file at ClinicalTrials.gov.
The record links to 6 conditions, with Anesthesia appearing as the primary indexed condition, and to 2 interventions - of which Admixture of propofol and etomidate at a ratio by volume of 75%/25% (P7E2) is the first listed.
NCT05358535 reports 1 study location spanning 1 distinct geographic area - top geographies include Texas.
Frequently Asked Questions
What is clinical trial NCT05358535 about?
NCT05358535 is a clinical study titled "Propofol and Etomidate Admixtures Comparisons Trial (PEAC Trial)". The purpose of this study is to evaluate the hemodynamics and adverse event profile in comparison between two treatment arms, one using an admixture of propofol and etomidate at a ratio by volume of 25%/75% (P2E7), and one using an admixture of propofol and etomidate at a ratio by volume of 75%/25% ...
What is the current status of trial NCT05358535?
This trial is currently recruiting. It is a Phase 3 study. The enrollment target is 200 participants. The study started on 2022-09-19. Estimated completion is 2027-03.
What conditions does trial NCT05358535 study?
This clinical trial studies the following conditions: Anesthesia, Anesthesia Complication, Anesthesia; Adverse Effect, Anesthesia; Reaction, Propofol Adverse Reaction.
What interventions are being tested in trial NCT05358535?
The interventions under investigation include: Admixture of propofol and etomidate at a ratio by volume of 75%/25% (P7E2) (DRUG), Admixture of propofol and etomidate at a ratio by volume of 25%/75% (P2E7) (DRUG).
Who is sponsoring clinical trial NCT05358535?
This trial is sponsored by University of Texas Southwestern Medical Center, which has 837 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05358535 being conducted?
This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Anesthesia
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Sedation During Endoscopy Using Remimazolam: Efficacy in a Novel Exploration
RECRUITING · Phase 3
-
A Study to Compare the Long-term Outcomes After Two Different Anaesthetics
ACTIVE NOT RECRUITING · Phase 3
-
Impact of Intraoperative Fluid Management on Electrolyte and Acid-base Variables
COMPLETED · Phase 3
-
Use of Dexmedetomidine to Reduce Emergence Delirium Incident in Children
COMPLETED · Phase 3
-
Lung Recruitment Maneuver as a Potential Predictor of Fluid Responsiveness in Mechanically Ventilated Pediatric Patients
RECRUITING
-
Total Intravenous Versus Inhalational Anesthesia- A Geriatric Anesthesia Study
RECRUITING · Phase 4
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.